MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

"We're thrilled to collaborate with Mayo Clinic to harness clinical and scientific expertise to develop therapeutics that could meaningfully improve patient lives across various conditions," said Christopher Marlett, CEO and Co-Founder of MDB. Founded in 1997, MDB Capital focuses on launching "Big Ideas" into valuable public companies with a better approach to public venture capital. This approach involves community-driven financings of pre-revenue, earlystage deep technology companies through early public ...